HDCN Article Review/Hyperlink

Ridker PM, MacFadyen JG, Everett BM, et al, for the CANTOS Trial Group

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Lancet (Jan) 391:319-328,

The abstract of this paper is available from the Lancet. Click here for the abstract.
         Related Folders:

Return to Home